Showing results (1481-1490 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|September 2, 2018
A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumorsKhalid Jazieh, Julian Molina, Jacob Allred, et al.Investigational New Drugs|May 31, 2018
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trialAkira Nakao, Junji Uchino, Fumiyasu Igata, et al.Investigational New Drugs|April 12, 2018
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumoursKyaw L Aung, Anthony B El-Khoueiry, Karen Gelmon, et al.Investigational New Drugs|May 30, 2018
Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancerMaha M Eissa, Cherine A Ismail, Mervat Z El-Azzouni, et al.Investigational New Drugs|May 25, 2019
Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancerQing-Hua Liu, Hong-Mei Yong, Qing-Xin Zhuang, et al.Investigational New Drugs|May 2, 2019
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignanciesNoboru Yamamoto, Baek-Yeol Ryoo, Bhumsuk Keam, et al.Investigational New Drugs|January 1, 1987
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometryM C Malet-Martino, P Servin, J Bernadou, et al.Investigational New Drugs|November 15, 2017
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancerXuenong Ouyang, Meiqi Shi, Fangwei Jie, et al.Investigational New Drugs|November 8, 2019
7-Chloroquinoline-1,2,3-triazoyl carboxamides induce cell cycle arrest and apoptosis in human bladder carcinoma cellsMariana S Sonego, Natália V Segatto, Lucas Damé, et al.Investigational New Drugs|June 1, 1988
Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin lymphomaK E LandysPageof 372